doi:10.3969/j.issn.1004-583X.2025.12.012

Abstract

CLC Number:

R541.7

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2025.12.012

https://www.lchc.cn/EN/Y2025/V40/I12/1119

References 30

[1]	Meier C, Bietenbeck M, Theofanidou M, et al. First-pass perfusion imaging using cardiovascular magnetic resonance in patients with various cardiac implantable electronic devices[J]. Clin Res Cardiol, 2025,14. doi:10.1007/s00392-025-02636-1.
[2]	Ruiz Mateas F, Pérez MA, García López F, et al. Magnetic resonance imaging in patients with cardiac implantable electronic devices: The RESONANCE Spanish registry[J]. Europace, 2024, 26(11):euae277. doi:10.1093/europace/euae277.
[3]	Russo RJ, Gakenheimer-Smith L, Birgersdotter-Green UM, et al. HRS call-to-action: Improved MRI access for patients with cardiovascular implantable electronic devices[J]. Heart Rhythm, 2025, 22(9):e821-e836. doi:10.1016/j.hrthm.2025.04.028.
[4]	Barison A, Baritussio A, Cipriani A, et al. Cardiovascular magnetic resonance: What clinicians should know about safety and contraindications[J]. Int J Cardiol, 2021, 331:322-328. doi:10.1016/j.ijcard.2021.02.003.
[5]	Fogante M, Volpato G, Esposto Pirani P, et al. Cardiac magnetic resonance and cardiac implantable electronic devices: Are they truly still “Enemies”[J]. Medicina (Kaunas), 2024, 60(4):522. doi:10.3390/medicina60040522.
[6]	Ainslie M, Miller C, Brown B, et al. Cardiac MRI of patients with implanted electrical cardiac devices[J]. Heart, 2014, 100(5):363-369. doi:10.1136/heartJNL-2013-304324. pmid: 23872585
[7]	Yang E, Suzuki M, Nazarian S, et al. Magnetic resonance imaging safety in patients with cardiac implantable electronic devices[J]. Trends Cardiovasc Med, 2022, 32(7):440-447. doi:10.1016/j.tcm.2021.08.001.
[8]	De Leon-Benedetti LS, Ramirez-Suarez KI, Otero HJ, et al. How we do it: Cardiac implantable devices are not a contraindication to MRI: Time for a paradigm shift[J]. Pediatr Radiol, 2024, 54(6):863-875. doi:10.1007/s00247-024-05902-y. pmid: 38488925
[9]	Indik JH, Gimbel JR, Abe H, et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices[J]. Heart Rhythm, 2017, 14(7):e97-e153. doi:10.1016/j.hrthm.2017.04.025.
[10]	Poh PG, Liew C, Yeo C, et al. Cardiovascular implantable electronic devices: A review of the dangers and difficulties in MR scanning and attempts to improve safety[J]. Insights Imaging, 2017, 8(4):405-418. doi:10.1007/s13244-017-0556-3.
[11]	Miller JD, Nazarian S, Halperin HR. Implantable electronic cardiac devices and compatibility with magnetic resonance imaging[J]. J Am Coll Cardiol, 2016, 68(14):1590-1598. doi:10.1016/j.jacc.2016.06.068. pmid: 27687201
[12]	Rowe MK, Shanahan L. Cardiac implantable electronic devices: An update[J]. Aust J Gen Pract, 2024, 53(7):430-435. doi:10.31128/AJGP-05-23-6847. pmid: 38957055
[13]	Martin ET, Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla[J]. J Am Coll Cardiol, 2004, 43(7):1315-1324. doi:10.1016/j.jacc.2003.12.016. pmid: 15063447
[14]	Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices[J]. Ann Intern Med, 2011, 155(7):415-424. doi:10.7326/0003-4819-155-7-201110040-00004. pmid: 21969340
[15]	Nazarian S, Hansford R, Rahsepar AA, et al. Safety of magnetic resonance imaging in patients with cardiac devices[J]. N Engl J Med, 2017, 377(26):2555-2564. doi:10.1056/NEJMoa1604267.
[16]	Ma YD, Watson RE Jr, Olson NE, et al. Safety of magnetic resonance imaging in patients with surgically implanted permanent epicardial leads[J]. Heart Rhythm, 2023, 20(8):1111-1118. doi:10.1016/j.hrthm.2023.04.003.
[17]	Vuorinen AM, Paakkanen R, Karvonen J, et al. Magnetic resonance imaging safety in patients with abandoned or functioning epicardial pacing leads[J]. Eur Radiol, 2022, 32(6):3830-3838. doi:10.1007/s00330-021-08469-6.
[18]	Fluschnik N, Tahir E, Erley J, et al. 3 Tesla magnetic resonance imaging in patients with cardiac implantable electronic devices: A single centre experience[J]. Europace, 2023, 25(2):571-577. doi:10.1093/europace/euac213.
[19]	Barison A, Ricci F, Pavon AG, et al. Cardiovascular magnetic resonance in patients with cardiac electronic devices: Evidence from a multicenter study[J]. J Clin Med, 2023, 12(20):6673. doi:10.3390/jcm12206673.
[20]	Bhuva AN, Moralee R, Brunker T, et al. Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices[J]. Eur Heart J, 2022, 43(26):2469-2478. doi:10.1093/eurheartj/ehab350.
[21]	Lanz H, Strauβ K, Höpler J, et al. Safety of magnetic resonance imaging in patients with cardiac implantable electronic devices[J]. J Cardiovasc Dev Dis, 2024, 11(10):313. doi:10.3390/jcdd11100313.
[22]	Lee EM, Ibrahim EH, Dudek N, et al. Improving MR image quality in patients with metallic implants[J]. Radiographics, 2021, 41(4):E126-E137. doi:10.1148/rg.2021200092.
[23]	Sasaki T, Hansford R, Zviman MM, et al. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators[J]. Circ Cardiovasc Imaging, 2011, 4(6):662-670. doi:10.1161/CIRCIMAGING.111.965764. pmid: 21946701
[24]	Vuorinen AM, Lehmonen L, Karvonen J, et al. Reducing cardiac implantable electronic device-induced artefacts in cardiac magnetic resonance imaging[J]. Eur Radiol, 2023, 33(2):1229-1242. doi:10.1007/s00330-022-09059-w.
[25]	Buˇci'c D, Hrabak-Paar M. Multimodality imaging in patients with implantable loop recorders: Tips and tricks[J]. Hellenic J Cardiol, 2024, 77:93-105. doi:10.1016/j.hjc.2023.12.001.
[26]	Bhuva AN, Kellman P, Graham A, et al. Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices[J]. Int J Cardiol, 2019, 279:72-78. doi:10.1016/j.ijcard.2019.01.005. pmid: 30642645
[27]	Löbe S, Paetsch I, Hilbert S, et al. Evaluation of the right heart using cardiovascular magnetic resonance imaging in patients with cardiac devices[J]. Int J Cardiol, 2020, 316:266-271. doi:10.1016/j.ijcard.2020.05.002. pmid: 32389768
[28]	Almeida AG, António N, Saraiva C, et al. Consensus document on magnetic resonance imaging in patients with cardiac implanted electronic devices. Documento de consenso sobre a realização de ressonância magnética em doentes com dispositivos cardíacos electrónicos implantados[J]. Rev Port Cardiol (Engl Ed), 2021, 40(1):41-52. doi:10.1016/j.repc.2020.05.009.
[29]	Bishara D, Hong K, Davó-Jiménez M, et al. Highly accelerated real-time cine MRI pulse sequence for cardiac implantable electronic devices and arrhythmias[J]. Radiol Cardiothorac Imaging, 2025, 7(6):e240554. doi:10.1148/ryct.240554.
[30]	Soni A, Srinivasa V, TB, Janorkar P, et al. Superior metal artifact reduction with MAVRIC-SL versus STIR in lumbar spine instrumentation: A retrospective analysis of 84 patients[J]. Global Spine J, 2025, 12. doi:10.1177/21925682251397909.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 30

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Zhenliang, Zhou Yangjie, Wen Wei, Li Wanneng, Xi Binwu, Zhao Xu, Liu Qifang. Mapping and ablation on the non-coronary cusp for treating para-Hisian premature atrial contractions and atrial tachycardia [J]. Clinical Focus, 2025, 40(10): 904-909.
[2]	Liu Jia, Yang Fengyu, Guo Mengya, Wu Zhuowei, Zhang Hanwen, Wang Yixuan, Chen Chunhong, Zhang Fang. The safety and efficacy of low-dose rivaroxaban in elderly patients with renal insufficiency and non-valvular atrial fibrillation [J]. Clinical Focus, 2025, 40(6): 509-512.
[3]	. [J]. Clinical Focus, 2025, 40(6): 558-563.
[4]	Zhu Chunyu, Lin Chunyi, Weng Lan, Yang Xunjie, Dong Dihui. Efficacy and safety of high-power short-duration on the modified box isolation for persistent atrial fibrillation [J]. Clinical Focus, 2024, 39(10): 915-920.
[5]	Wang Yihan, Qin Xuyan, Han Xuanze, Wang Yingjie, Gao Feifei, Chen Chunhong, Zhang Lingnan, Zhang Fang. Efficacy and safety of rivaroxaban therapy in elderly patients with non-valvular atrial fibrillation who had a HASBLED score≥3 [J]. Clinical Focus, 2024, 39(2): 121-124.
[6]	. [J]. Clinical Focus, 2024, 39(2): 168-171.
[7]	Zhang Fang, Zhang Yichao, Jia Xinwei, Li Jianlong, Chen Chunhong. Analysis of one-year follow-up results of ≥75-year-old atrial fibrillation inpatients with high CHA2DS2-VASc score [J]. Clinical Focus, 2023, 38(2): 117-120.
[8]	Li Weiwei, Li Yanan. Left atrial volume index predicts atrial fibrillation recurrence after radiofrequency ablation: A meta-analysis [J]. Clinical Focus, 2022, 37(11): 965-968.
[9]	An Jingjing, Wang Xiaojuan, Deng Aiyun. Radiofrequency ablation in treating pre-excited atrial fibrillation recurrence: A meta analysis [J]. Clinical Focus, 2022, 37(10): 899-904.
[10]	. [J]. Clinical Focus, 2022, 37(10): 946-949.
[11]	Ma Jinghong, Yang Qian, Jia Yongjian, Dang Yi. Risks of cardiac tamponade resulting from uninterrupted novel oral anticoagulants and uninterrupted warfarin during perioperative period of catheter ablation of atrial fibrillation: A meta-analysis [J]. Clinical Focus, 2022, 37(9): 773-778.
[12]	Zhang Haifu, Ye Xiangqing, Chen Zhexu, Chen Shijian, Yang Dong, Zhang Xingwei. Effects of moderate exercise on the prognosis of patients with atrial fibrillation:A systematic review and Meta-analysis [J]. Clinical Focus, 2022, 37(6): 485-489.
[13]	Zhao Meili, Xiao Liyuan, Liu Lin, Kang Chao, Zhang Qiuxiang. Correlation between NT-proBNP, hs-CRP, left atrium diameter and chronic heart failure concurrent with atrial fibrillation [J]. Clinical Focus, 2021, 36(5): 412-415.
[14]	Lu Yuqin, Li Yingdong, Liu Kai. Role of serum MMP-1, MMP-3, TIMP-1 and Hcy levels in patients with hypertension complicated with atrial fibrillation [J]. Clinical Focus, 2020, 35(11): 976-979.
[15]	. [J]. Clinical Focus, 2020, 35(11): 1030-1034.